Concord Biotech Limited — Others, 31-05-2025: Copy of Newspaper Publication

Concord Biotech Limited has announced a board meeting to consider the financial results for the quarter and half-year. For the year ended March 31, 2025, the company reported total income from operations of Rs. 764.34 Cr, profit before tax of Rs. 497.25 Cr, and profit after tax of Rs. 374.81 Cr. Total comprehensive income was Rs. 347.16 Cr, with earnings per share at Rs. 15.46. These results were reviewed by the audit committee and approved by the board, reflecting strong operational performance and profitability.